Pharming (NASDAQ:PHAR) reported quarterly earnings of $0.02 per share which met the analyst consensus estimate. This is a 66.67 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $90.200 million which missed the analyst consensus estimate of $100.625 million by 10.36 percent. This is a 3.22 percent decrease over sales of $93.200 million the same period last year.